ACUTE HERPETIC
GINGIVOSTOMATITIS
Uzma Jan
3rd year B.D.S
AHG is a viral infection of the oral mucous membrane caused by
herpes simplex virus-I(HSV-I).
Occurs most frequently in infants & Children younger than 6 years .
CLINICAL FEATURES
 ORAL SIGNS :
 Appears as a diffuse shiny
erythematous edema & gingival
bleeding.
 Discrete spherical clusters of vesicle
dispersed in different areas (labial
buccal mucosa hard palate pharynx and
tongue)
 Course of disease is 7-10 days
 SYMPTOMS:
 Generalized soreness of oral cavity
 Ruptured vesicles sensitive t0 touch
thermal changes and food
EXTRA ORAL & SYSTEMIC SIGN &
SYMPTOMS
 1-3 days of fever , loss of appetite and myalgia
 Cervical lymphadenopathy is present.
 After the Primary infection the virus remains latent in the nerve tissues.
 If reactivation occurs it causes herpes labialis (cold sore).
HISTOPATHOLOGY
 The virus targets the epithelial cells which show “ballooning
degeneration”
 These cells are called Tzanck cells.
 Infected cells fuse , forming multinucleated cells and IC edema leads to
formation of an intraepithelial vesicles that rupture and develops a sec.
inflammatory response with a fibro purulent exudate
 Discrete ulceration have a central portion of acute inflammation with
exudate surrounded by engorged blood vessels.
DIAGNOSIS
 Established from pts history & clinical findings.
 HSV isolation by cell culture is the gold standard.
 Tzanck smear
D/D
 Necrotizing Ulcerative Gingivitis
 Erythema multiforme
 Stevens-Johnson Syndrome
 Apthous Stomatitis (canker sores)
COMMUNICABILITY
 Contagious
TREATMENT
 1. Local Applications:
 *Using topical lignocaine and benzocaine in mild cases.
 *topical steroids like triamcinolone and clobetasol application in severe
cases.
 2. Systemic therapy :
 *pentroxifylline daspsone short bursts of systemic steroids &
thalidomide have been used to reduce the no. of ulcers and recurrence.
Acute herpetic gingivostomatitis

Acute herpetic gingivostomatitis

  • 1.
  • 2.
    AHG is aviral infection of the oral mucous membrane caused by herpes simplex virus-I(HSV-I). Occurs most frequently in infants & Children younger than 6 years .
  • 3.
    CLINICAL FEATURES  ORALSIGNS :  Appears as a diffuse shiny erythematous edema & gingival bleeding.  Discrete spherical clusters of vesicle dispersed in different areas (labial buccal mucosa hard palate pharynx and tongue)  Course of disease is 7-10 days  SYMPTOMS:  Generalized soreness of oral cavity  Ruptured vesicles sensitive t0 touch thermal changes and food
  • 4.
    EXTRA ORAL &SYSTEMIC SIGN & SYMPTOMS  1-3 days of fever , loss of appetite and myalgia  Cervical lymphadenopathy is present.
  • 5.
     After thePrimary infection the virus remains latent in the nerve tissues.  If reactivation occurs it causes herpes labialis (cold sore).
  • 6.
    HISTOPATHOLOGY  The virustargets the epithelial cells which show “ballooning degeneration”  These cells are called Tzanck cells.  Infected cells fuse , forming multinucleated cells and IC edema leads to formation of an intraepithelial vesicles that rupture and develops a sec. inflammatory response with a fibro purulent exudate  Discrete ulceration have a central portion of acute inflammation with exudate surrounded by engorged blood vessels.
  • 7.
    DIAGNOSIS  Established frompts history & clinical findings.  HSV isolation by cell culture is the gold standard.  Tzanck smear
  • 8.
    D/D  Necrotizing UlcerativeGingivitis  Erythema multiforme  Stevens-Johnson Syndrome  Apthous Stomatitis (canker sores)
  • 9.
  • 10.
    TREATMENT  1. LocalApplications:  *Using topical lignocaine and benzocaine in mild cases.  *topical steroids like triamcinolone and clobetasol application in severe cases.  2. Systemic therapy :  *pentroxifylline daspsone short bursts of systemic steroids & thalidomide have been used to reduce the no. of ulcers and recurrence.